ABSINasdaqServices-Commercial Physical & Biological ResearchFiscal year ends December 31
Absci Corp
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 11, 2026
$8.54+0.29 (+3.52%)
Close on Oct 19, 2026
- Market cap
- $1.34B
- P/E (TTM)
- –
- Dividend yield
- –
Share price
+$4.01 (+88.52%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Earnings
Absci Corp saw revenue fall 62.3% to $1.56M over the twelve months to Jun 30, 2026. Free cash flow was -$108.97M.
Revenue
$1.56M
-62.3% vs. a year earlier
Operating income
-$126.20M
TTM Q2 2026
Free cash flow
-$108.97M
TTM Q2 2026
EPS, diluted
-$0.80
TTM Q2 2026
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $1.34B
- P/E ratio
- –
- Price to sales
- 861.50
- Price to book
- 5.46
- Dividend yield
- –
- Free cash flow yield
- -8.10%
Fundamentals
- Revenue
- $1.56M
- Net income
- -$121.08M
- EPS, diluted
- -$0.80
- Free cash flow
- -$108.97M
- Book value per share
- $1.56
- Diluted shares
- 157M
Seven years at a glance
Fiscal years 2019 to 2025 and trailing twelve months, USD
Revenue
$1.56M-62.3% YoY
Operating income
-$126.20M
Net income
-$121.08M
EPS, diluted
-$0.80
Free cash flow
-$108.97M
Reported periodTrailing twelve months